Fidasimtamab, also known as DLTV – 1504, represents the novel strategy in the fight against multiple myeloma. It is a targeted molecule designed to simultaneously engage CD3-positive immune cells and https://www.targetmol.com/compound/fidasimtamab
{Fidasimtamab: This Emerging Option in Multiple Blood Treatment ?
Internet - 3 hours ago fidasimtamab-antibody229736
Web Directory Categories
Web Directory Search
New Site Listings